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 The year of 2020 was one that will live in our minds forever. Many political events, civil 
rights movements, and other historical movements took place. Though these moments 
themselves should be remembered, the most life-altering experience for most people was the 
pandemic. The world was halted, jobs were lost, relationships ruined, some struggling for 
survival. All of this caused by a microscopic enemy, the SARS-CoV-2 coronavirus.  
 Patients started to come to hospitals in Wuhan, China with a pneumonia with an 
unknown cause. Late in December of 2019, a cluster of these cases appeared. Health care 
workers quickly noted that these patients all had a common experience, going to a Hunan 
market. This suggested that the cause of this pneumonia-mimicking disease was a transmissible 
agent. With this recognition, shotgun sequencing was used to identify the etiologic agent by early 
January, with the development of a diagnostic PCR test just two days after that. The 
advancement of scientific technology shines here and is quite astonishing. This same process 
took four years with HIV. This sequencing allowed scientists to recognize the virus as a beta 
coronavirus, the biology of this virus will be discussed later on. They believe this virus came 
from bats originally, but is also very closely related to a coronavirus that has been identified 
from pangolins. They hypothesize the transmission went from bat to pangolin, back to bats, and 
then to humans, although the epidemiology was not certain at this time.  
 This is not the first pathogenic human coronavirus to hit the scene fortunately. In 2003 
we had SARS that caused 8,000 cases with an 11% fatality rate, and MERS in 2011 causing 
2,500 cases with a 34% fatality rate. Both of these did not have a very high transmissibility 
though. Then in this last year SARS-CoV-2 ravaged the planet, causing 171 million cases to this 
day, with only 3.6 million deaths, for a fatality rate of 0.5-1%. Some researchers claim that a 
virus with SARS-CoV-2 transmissibility and MERS fatality rate is one to invoke great fear. 
While these past epidemics were tragic in and of themselves, they proved beneficial when the 
COVID-19 pandemic hit the world. Researchers had a head start on some of the biology, 
transmission tactics, and epidemiology of coronaviruses because of these past outbreaks.  
 As mentioned, humans have long been infected by coronaviruses, especially because it is 
one of the viruses responsible for the common cold. It was previously established that the 
diseases caused by these viruses are highly contagious viral infections that can be spread through 
inhalation or ingestion of viral droplets. So what makes up this virus?  
 The SARS-CoV-2 genome is approximately 30,000 nucleotides long, encoding for four 
structural proteins and several non-structural ones. The four structural proteins are the 
nucleocapsid protein (N), membrane protein (M), spike protein (S), and the envelope (E) protein. 
The capsid is the protein shell, where inside there is an N-protein bound to the virus’s single 
positive strand of RNA. The M protein is most abundant on the viral surface and is believed to 
be the central organizer for the virus assembly. The E protein is a small membrane protein 
composed of approximately 76 amino acids and plays an important role in virus assembly, 
membrane permeability of the host cell, and virus-host cell interaction. Immediately, the S 
protein and the Hemagglutinin-esterase dimer (HE) were identified as a main focus for 
researchers. The S protein is integrated over the surface of the virus and mediates the attachment 
of the virus to the host cell surface receptors and fusion between the viral and host cell 
membranes. The HE is thought to be important for the infection of the host cell (Boopathi, 
Subramanian et al.).  
 The SARS-CoV-2 genome contains only 13 genes, but more than 27 proteins are made 
through some viral trickery employed by the virus. Even though the virus can utilize the cellular 
machinery available to it, it needs to abide by the rules these machinery function by. In 
eukaryotic cells like ours, we get one gene made into a protein per messenger RNA (mRNA). 
The 5’ cap on this mRNA strand recruits the ribosome, which starts reading when it hits a start 
codon, and keeps reading until it runs into a stop codon and then falls off. Everything 
downstream from that stop signal is not seen by the ribosome. This is a problem for the virus 
because it does not just have one gene on its mRNA, it has 13. Lucky for the virus, it has a way 
to get around it. It encodes multiple different proteins in a single gene, the ‘giant gene’, ORF. It 
does this by inserting these genes into just the one open reading frame by removing those start 
and stop signals. This allows for up to 16 proteins to be made just from the ORF. The virus also 
encodes its own protease enzyme, which allows the new polyprotein to be sliced into its 
individual protein subunits (Hartenian et al.).   
 What about the genes downstream of the ORF? The virus uses a second strategy which 
involves generating new RNA copies which are sub-genomic length (sub-genomic RNAs). They 
all have the same 3’ end but vary in lengths based off of how many genes they are encoding. 
This happens because as the viral copying machine is making these RNAs, at the boundary 
between each of these genes on the right-hand side is a transcriptional regulatory sequence. This 
signal basically gives the RNA copying machine the option of stopping or continuing on, and it 
is not clear exactly how this works yet. By making these sub-genomic RNAs, each of the 
downstream genes has the chance to be represented as the first gene that the ribosome sees.  
 Additionally, all RNA viruses need to encode their own RNA copying enzymes, called an 
RNA-dependent RNA Polymerase (RDRP). This is because our own cells do not have this type 
of enzyme for the virus to steal. The coronavirus replisome is highly sophisticated and may even 
challenge some DNA replisomes. Generally, RNA copying enzymes make a lot of mistakes such 
as inserting the wrong nucleotide every thousand bases. These error-prone polymerases are what 
drives the high rates of mutations seen in many RNA viruses, but we do not see this same thing 
with this coronavirus. The reason for this is because this virus encodes its own proofreading 
mechanism. This little “machine” follows along with the polymerase, and if the polymerase 
makes a matching error, the editor kicks that nucleotide out and allows for the correct match to 
replace it. This is also a possible explanation for why this coronavirus genome is much larger 
than other RNA viruses.  
 So where does all of this take place, and how has our cell not detected it? Well, the virus 
creates new “rooms” into which it can go and replicate. These “rooms” are actually 
interconnected double membrane vesicles that are taken from the endoplasmic reticulum, and are 
referred to as replication and transcription complexes (RTCs). There are two possible reasons the 
virus does this. First, it allows the virus to copy its genome in a secret place. The cytoplasm of 
the host cell is full of sensor proteins that are looking for anything foreign. If they detect 
something unusual, they will alert the cell which in turn alerts all neighboring cells and induces a 
broader immune response. A prime suspect these proteins are looking for is double stranded 
RNAs because these do not usually form in our cells. Because it is inevitably that the replication 
of the viral genome will produce double stranded RNAs, the virus hides its replication in a 
compartment where it cannot be detected by the host. Second, it allows the virus to concentrate 
everything it needs to copy and transcribe its genome in one place, making it a more efficient 
process (Knoops et al.).  
Once the methods of this coronavirus were understood in more detail, countries needed to 
decide what they were going to enforce to stop the spread of this disease. Europe was the center 
of the virus in March and April, but was able to bring that surge right back down. They enforced 
an actual nationwide lockdown, where normally life was completely stopped. In France, the third 
lockdown meant that most shops will remain closed, and there was a nightly curfew at 7pm. 
Spain mandated masks for locals and tourists even outdoors. In Greece, people were only 
allowed to leave their homes between the hours of 5am and 9pm only if they have a good reason 
for doing so – such as a doctor’s appointment or going to work. Earlier in the year the Czech 
Republic had the highest weekly incidence of COVID-19 infection in the world. They mandated 
that only two people were allowed to meet at a time, unless they were in the same household, a 
nightly curfew, and all non-essential shops were closed. In the United States, we had a mask 
mandate and a shut down. The United States had a lot more politicized approach it seemed, 
which could explain why we never reached an acceptable baseline in case numbers.  
 Another critical aspect of this pandemic is the effect it had on individual’s mental health. 
It goes to say that these were stressful times for most people, being locked in your house, not 
seeing those you care about, and feeling pressured to work if seen as an essential worker. A 
survey of 562 people from May 2020, revealed an increase in alcohol and cannabis use among 
people in the United States, suggesting people turned to these substances to relieve their stress 
and anxiety. This same survey showed that 43% of these people were feeling nervous, anxious, 
or on edge (Lee, 2020). In the United Kingdom, other studies show that 37.5% of people met 
clinical criteria for generalized anxiety, depression, or health anxiety at that time (Rettie, 2020).  
Before going into vaccination efforts, it is important to discuss a central idea known to 
immunology. There are three main properties of the immune system- specificity, diversity, and 
memory. There was a theoretical construct built quite some time ago, called the clonal selection 
theory, constructed around ideas about the immune system. It said that the immune system is 
composed of individual clones of cells, many different cells that are different from each other by 
their specific receptors. These clones have a predetermined receptor. When the virus comes into 
the system, the cell that has that receptor that recognizes it will expand through clonal expansion. 
What this means is that when you get the pathogen coming back a second time, you have more 
cell that can recognize it (Arneth, 2018).  
While there were many efforts going into vaccines, three companies were able to get 
through the process and receive acceptance for emergency use – Moderna, Pfizer, and Johnson & 
Johnson. Within 66 days of the SARS-CoV-2 genomic sequence being published, a phase 1 
clinical trial for Moderna’s mRNA vaccine happened, which is a world record. They were able to 
accomplish this because of the pre-clinical development spent after the MERS outbreak in 
anticipation of a coronavirus outbreak. Essentially this vaccine protects against lung and nose 
SARS-CoV-2 replication (Corbett, 2020). Both Pfizer and Moderna vaccines are mRNA based, 
which are a new type of vaccine. These vaccines essentially teach our cells how to make a 
protein that triggers and immune response in our body. This happens because this new protein is 
displayed on the cell surface and our immune systems recognize that the protein does not belong 
there and begins producing antibodies and building up our immune response. They do not use an 
inactive form of the virus, and the mRNA never interacts with our DNA in any way. The 
Johnson & Johnson vaccine uses the traditional approach (CDC, 2021).  
Vaccinations have been critical for this pandemic, many health officials explained they 
do not think the virus would leave our lives if we did not achieve herd immunity. Since there are 
cases where people can get infected twice, vaccines seemed like the best option. To this day, 
there are 136 million people fully vaccinated, and 169 million people with at least one dose. This 
means 41% of the U.S. population is almost entirely immune, which is not enough to achieve 
herd immunity, but the numbers are growing every day. Pfizer has taken the lead in vaccine 
numbers, counting in at 70 million fully vaccinated people. Serious side effects are extremely 
rare, with the most common side effect reported being fatigue and pain at the injection site 
(CDC).  
In the end, this pandemic has shown a lot about the human population that we might not 
have seen without it. We were fortunate for the past coronavirus outbreaks, otherwise we would 
not have had vaccines as quickly as we did. It is important to pay attention to every disease that 
hits our population, no matter how small, because it may come back bigger just like the 
coronavirus population did to us.  
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